Deepta Bhattacharya

Deepta Bhattacharya

Auto-generated profile, based on publicly available information

Deepta Bhattacharya

Department of Immunobiology, University of Arizona College of Medicine, Tucson, AZ 85724, USA; BIO5 Institute, University of Arizona, Tucson, AZ 85724, USA; Department of Surgery, University of Arizona College of Medicine, Tucson, AZ 85724, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Immunity
Verified
Journal Article
Closed access
TRTyler J. Ripperger
Tyler J. Ripperger
JUJennifer L. Uhrlaub
Jennifer L. Uhrlaub
MWMakiko Watanabe
Makiko Watanabe
RWRachel Wong
Rachel Wong
YCYvonne Castaneda
Yvonne Castaneda
DBDeepta Bhattacharya
Deepta Bhattacharya

30 September 2021 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
RSRachna T. Shroff
Rachna T. Shroff
PCPavani Chalasani
Pavani Chalasani
RWRan Wei
Ran Wei
DPDaniel Pennington
Daniel Pennington
GQGrace Quirk
Grace Quirk
DBDeepta Bhattacharya
Deepta Bhattacharya

1 November 2020 in Immunity
Verified
Journal Article
Closed access
RWRachel Wong
Rachel Wong
JBJulia A. Belk
Julia A. Belk
JGJennifer Govero
Jennifer Govero
JUJennifer L. Uhrlaub
Jennifer L. Uhrlaub
DRDakota Reinartz
Dakota Reinartz
DBDeepta Bhattacharya
Deepta Bhattacharya

1 August 2018 in Cell Reports
Verified
Journal Article
Open access
WLWing Y. Lam
Wing Y. Lam
AJArijita Jash
Arijita Jash
CYCong-Hui Yao
Cong-Hui Yao
LDLucas D’sOuza
Lucas D’sOuza
RWRachel Wong
Rachel Wong
DBDeepta Bhattacharya
Deepta Bhattacharya
Plasma cell survival and the consequent duration of immunity vary widely with infection or vaccination. Using fluorescent glucose analog uptake, we defined multiple developmentally independent mouse plasma cell populations with varying lifespans. Long-lived plasma cells imported more fluorescent glucose analog, expressed higher surface levels of the amino acid transporter CD98, and had more autophagosome mass than did short-lived cells. Low amino acid concentrations triggered reductions in both antibody secretion and mitochondrial respiration, especially by short-lived plasma cells. To explain these observations, we found that glutamine was used for both mitochondrial respiration and anaplerotic reactions, yielding glutamate and aspartate for antibody synthesis. Endoplasmic reticulum (ER) stress responses, which link metabolism to transcriptional outcomes, were similar between long- and short-lived subsets. Accordingly, population and single-cell transcriptional comparisons across mouse and human plasma cell subsets revealed few consistent and conserved differences. Thus, plasma cell antibody secretion and lifespan are primarily defined by non-transcriptional metabolic traits.

1 January 2018 in Trends in Immunology
Verified
Journal Article
Closed access
WLWing Y. Lam
Wing Y. Lam
DBDeepta Bhattacharya
Deepta Bhattacharya

7 June 2018 in JCI Insight
Verified
Journal Article
Closed access
PDF file
LALuigi Adamo
Luigi Adamo
LSLora J. Staloch
Lora J. Staloch
CRCibele Rocha-Resende
Cibele Rocha-Resende
SMScot Matkovich
Scot Matkovich
WJWenlong Jiang
Wenlong Jiang
DMDouglas L Mann
Douglas L Mann
Despite the long-standing recognition that the immune response to acute myocardial injury contributes to adverse left ventricular (LV) remodeling, it has not been possible to effectively target this clinically. Using 2 different in vivo models of acute myocardial injury, we show that pirfenidone confers beneficial effects in the murine heart through an unexpected mechanism that depends on cardiac B lymphocytes. Naive hearts contained a large population of CD19 + CD11b – CD23 – CD21 – IgD + IgM lo lymphocytes, and 2 smaller populations of CD19 + CD11b + B1a and B1b cells. In response to tissue injury, there was an increase in neutrophils, monocytes, macrophages, as well as an increase in CD19 + CD11b – B lymphocytes. Treatment with pirfenidone had no effect on the number of neutrophils, monocytes, or macrophages, but decreased CD19 + CD11b – lymphocytes. B cell depletion abrogated the beneficial effects of pirfenidone. In vitro studies demonstrated that stimulation with lipopolysaccharide and extracts from necrotic cells activated CD19 + lymphocytes through a TIRAP -dependent pathway. Treatment with pirfenidone attenuated this activation of B cells. These findings reveal a previously unappreciated complexity of myocardial B lymphocytes within the inflammatory infiltrate triggered by cardiac injury and suggest that pirfenidone exerts beneficial effects in the heart through a unique mechanism that involves modulation of cardiac B lymphocytes.